標(biāo)題: Titlebook: Gene Therapy for HIV; From Inception to a Gerhard Bauer,Joseph S. Anderson Book 2014 Gerhard Bauer and Joseph S. Anderson 2014 Anti-HIV ge [打印本頁(yè)] 作者: Stenosis 時(shí)間: 2025-3-21 17:53
書目名稱Gene Therapy for HIV影響因子(影響力)
書目名稱Gene Therapy for HIV影響因子(影響力)學(xué)科排名
書目名稱Gene Therapy for HIV網(wǎng)絡(luò)公開度
書目名稱Gene Therapy for HIV網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Gene Therapy for HIV被引頻次
書目名稱Gene Therapy for HIV被引頻次學(xué)科排名
書目名稱Gene Therapy for HIV年度引用
書目名稱Gene Therapy for HIV年度引用學(xué)科排名
書目名稱Gene Therapy for HIV讀者反饋
書目名稱Gene Therapy for HIV讀者反饋學(xué)科排名
作者: Urea508 時(shí)間: 2025-3-21 22:09
Animal Models Used in HIV Gene Therapy,animals. Human immune cells generated in vivo could then be infected with HIV, and anti-HIV gene therapy applications could be tested in these mice. Nonhuman primates are also utilized for HIV research; however, the simian immunodeficiency virus (SIV) or a hybrid HIV–SIV needs to be applied for viral challenges.作者: 殘廢的火焰 時(shí)間: 2025-3-22 01:57
2211-9353 le functional cure for HIV.Comprises a thorough and methodic.This Brief describes the concept and realization of gene therapy for HIV from the unique historic perspective and insight of two pioneers of the clinical applications of stem cell gene therapy for HIV..Gerhard Bauer applied ribozyme-anti-H作者: Expurgate 時(shí)間: 2025-3-22 06:29
Classical and Spatial Stochastic Processesanimals. Human immune cells generated in vivo could then be infected with HIV, and anti-HIV gene therapy applications could be tested in these mice. Nonhuman primates are also utilized for HIV research; however, the simian immunodeficiency virus (SIV) or a hybrid HIV–SIV needs to be applied for viral challenges.作者: 變態(tài) 時(shí)間: 2025-3-22 10:17 作者: 暴發(fā)戶 時(shí)間: 2025-3-22 15:55
Tommaso Ruggeri,Masaru Sugiyamaon of multiple genes, with their active anti-HIV component being RNA or protein based. Safety features have been engineered into latest generation lentiviral vectors, and efficient vector production methods based on transient plasmid transfection methods have been developed.作者: 暴發(fā)戶 時(shí)間: 2025-3-22 19:22 作者: conquer 時(shí)間: 2025-3-22 21:18
Exchange Modules and Exchange Rings,e can be expected. In the future, stem cells may also be generated from pluripotent stem cells, particularly induced pluripotent stem cells, promising large numbers of tested, HIV-resistant autologous stem cells for patients with HIV.作者: 領(lǐng)袖氣質(zhì) 時(shí)間: 2025-3-23 02:17 作者: commensurate 時(shí)間: 2025-3-23 08:24 作者: 偶像 時(shí)間: 2025-3-23 11:11
Stem Cells for HIV Gene Therapy,stem cells that were gene modified with anti-HIV genes. A pluripotent, anti-HIV gene-modified cell clone could be used to generate enough hematopoietic stem cells to engraft the recipient. The generation of a patient’s own gene-modified stem cells is possible by the use of autologous, induced pluripotent stem cells.作者: 軍火 時(shí)間: 2025-3-23 17:25
Is a Cure for HIV Possible?,e can be expected. In the future, stem cells may also be generated from pluripotent stem cells, particularly induced pluripotent stem cells, promising large numbers of tested, HIV-resistant autologous stem cells for patients with HIV.作者: PACT 時(shí)間: 2025-3-23 19:58
Bulk-Edge Dualities in Topological Matter,hematopoietic origin, derived from hematopoietic stem cells. Anti-HIV genes inserted into hematopoietic stem cells will be passed onto all progeny, including all the target cells for HIV. Newly arising cells will therefore be protected from the detrimental effects of HIV.作者: Obedient 時(shí)間: 2025-3-24 02:12
https://doi.org/10.1007/978-1-4615-6261-0Both vector and cellular products need to be manufacturing in a GMP facility designed for this purpose, and stringent release criteria need to be applied before they can be administered into patients in clinical trials.作者: 刺穿 時(shí)間: 2025-3-24 04:52 作者: 高興一回 時(shí)間: 2025-3-24 08:43 作者: ornithology 時(shí)間: 2025-3-24 10:58
Manufacturing of a GMP Grade Product for HIV Gene Therapy,Both vector and cellular products need to be manufacturing in a GMP facility designed for this purpose, and stringent release criteria need to be applied before they can be administered into patients in clinical trials.作者: organism 時(shí)間: 2025-3-24 16:37
Clinical Applications of HIV Gene Therapy,ovide continued benefits. Stem cell gene therapy offers to be a onetime treatment, but currently only low transduction efficiencies can be achieved. Future clinical trials of stem cell gene therapy need to be designed to overcome this problem.作者: 下邊深陷 時(shí)間: 2025-3-24 19:58
978-1-4939-0433-4Gerhard Bauer and Joseph S. Anderson 2014作者: Factual 時(shí)間: 2025-3-25 01:08
Gene Therapy for HIV978-1-4939-0434-1Series ISSN 2211-9353 Series E-ISSN 2211-9361 作者: 出血 時(shí)間: 2025-3-25 05:14 作者: 流利圓滑 時(shí)間: 2025-3-25 09:21
https://doi.org/10.1007/978-3-662-11325-7shed by the insertion of naked DNA and the application of nonviral gene transfer (transfection) or viral gene transfer (transduction) methods. These methods vary widely in their gene transfer efficacy and also in the duration of expression of the transferred gene. For durable gene expression, retrov作者: Abutment 時(shí)間: 2025-3-25 15:09
S?awomir Szymański,Piotr Bernatowiczhe first retroviral-mediated gene therapy clinical trials started in 1990, and the first stem cell gene therapy clinical trial (ADA deficiency), also retrovirally mediated, was initiated in 1994. The first stem cell gene therapy clinical trial for pediatric HIV was conducted in 1997, followed by a s作者: 萬(wàn)花筒 時(shí)間: 2025-3-25 17:45
Bulk-Edge Dualities in Topological Matter,uctive effects of HIV. Anti-HIV genes can be engineered to interfere with attachment, uncoating, reverse transcription, integration, expression, and budding of the virus. Target cells for HIV are CD4+ T cells, macrophages, monocytes, dendritic cells, and even brain microglia. All these cells are of 作者: 率直 時(shí)間: 2025-3-25 23:13 作者: 和平主義 時(shí)間: 2025-3-26 04:05
The Simple Symmetric Random Walk, types of stem cells. They can be obtained either from the bone marrow or by mobilization and subsequent apheresis from the peripheral blood. After transplantation, there is no rejection issue; however, a high-enough transduction efficiency to elicit a clinical benefit is difficult to obtain. Select作者: Cultivate 時(shí)間: 2025-3-26 07:41
Classical and Spatial Stochastic Processesouse models were refined and could be applied for engraftment of human hematopoietic stem cells, generating a functional human immune system in these animals. Human immune cells generated in vivo could then be infected with HIV, and anti-HIV gene therapy applications could be tested in these mice. N作者: 正式通知 時(shí)間: 2025-3-26 10:13 作者: 愛得痛了 時(shí)間: 2025-3-26 15:53
Classical Capacities of Bosonic Channels,by several groups: T cell gene therapy and stem cell gene therapy clinical trials. Both have their unique advantages and disadvantages, with T cell gene therapy offering easier access to HIV target cells and greater transduction efficiencies, however, with the necessity to repeat the procedure to pr作者: nurture 時(shí)間: 2025-3-26 18:51 作者: 隱士 時(shí)間: 2025-3-26 22:28 作者: 不妥協(xié) 時(shí)間: 2025-3-27 02:18
Principles of Gene Therapy,shed by the insertion of naked DNA and the application of nonviral gene transfer (transfection) or viral gene transfer (transduction) methods. These methods vary widely in their gene transfer efficacy and also in the duration of expression of the transferred gene. For durable gene expression, retrov作者: 暫時(shí)別動(dòng) 時(shí)間: 2025-3-27 05:44
History of Gene Therapy,he first retroviral-mediated gene therapy clinical trials started in 1990, and the first stem cell gene therapy clinical trial (ADA deficiency), also retrovirally mediated, was initiated in 1994. The first stem cell gene therapy clinical trial for pediatric HIV was conducted in 1997, followed by a s作者: 有毛就脫毛 時(shí)間: 2025-3-27 10:03 作者: Lacerate 時(shí)間: 2025-3-27 17:08 作者: SEMI 時(shí)間: 2025-3-27 21:46
Stem Cells for HIV Gene Therapy, types of stem cells. They can be obtained either from the bone marrow or by mobilization and subsequent apheresis from the peripheral blood. After transplantation, there is no rejection issue; however, a high-enough transduction efficiency to elicit a clinical benefit is difficult to obtain. Select作者: Merited 時(shí)間: 2025-3-28 00:24 作者: 放逐 時(shí)間: 2025-3-28 03:58 作者: 宣稱 時(shí)間: 2025-3-28 10:06
Clinical Applications of HIV Gene Therapy,by several groups: T cell gene therapy and stem cell gene therapy clinical trials. Both have their unique advantages and disadvantages, with T cell gene therapy offering easier access to HIV target cells and greater transduction efficiencies, however, with the necessity to repeat the procedure to pr作者: 不理會(huì) 時(shí)間: 2025-3-28 12:47
Is a Cure for HIV Possible?,nough number of HIV-resistant hematopoietic stem cells is transplanted into an HIV-infected recipient, eventually creating an immune system that can control the virus. This has been demonstrated in one patient who received a bone marrow transplant from a donor with a naturally occurring CCR5 deletio作者: 我沒有命令 時(shí)間: 2025-3-28 15:56
SpringerBriefs in Biochemistry and Molecular Biology381978.jpg作者: Coterminous 時(shí)間: 2025-3-28 20:16
Book 2014limitations and proper safety precautions and outline a path for a possible functional cure for HIV using stem cell gene therapy based on a cure already achieved with a bone marrow stem cell transplantation performed in Germany using donor stem cells with a naturally arising CCR5 mutation. In additi作者: concubine 時(shí)間: 2025-3-28 23:22
